ODYSSEY
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients who have Recently Experienced an Acute Coronary Syndrome.
- Stage
- klaar
- Medicine
- alirocumab
- Population
- ASCVD
- Phase
- III
- First Patient In
- 1 January 2012
- Last Patient In
- 1 November 2015
- Last Patient Last Visit
- 11 December 2017
Study Director
